赤子城科技(09911.HK)有意提供不超2億港元根據股份計劃從市場購買股份
格隆匯3月20日丨赤子城科技(09911.HK)公告,公司股份計劃的統一目的在於(其中包括)認可參與者對集團業績的貢獻,並通過向他們提供具有競爭力和公平的薪酬待遇以及分享集團的成就來挽留其爲集團繼續服務,就此公司董事會謹此宣佈,其當前有意在未來兩年內不時向爲管理公司股份計劃而任命的獨立專業受託人提供合共不超過2億港元的資金,以根據公司股份計劃從市場按現行市價購買公司股份。
董事會認爲,於現況下進行股份購買展示出公司對自身業務展望及前景充滿信心,且最終會爲公司帶來裨益及爲股東創造價值。董事會認爲,公司現有財務資源足以支持股份購買同時維持穩健的財務狀況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.